SPONSORED:

Azar calling GOP senators to back Grassley drug price plan

Azar calling GOP senators to back Grassley drug price plan
© Greg Nash

Secretary of Health and Human Services Alex Azar is calling Republican senators to encourage them to vote for a bill to lower drug prices being considered on Thursday in the Senate Finance Committee, according to sources familiar with the matter. 

The calls from Azar are a sign of the Trump administration’s support for the bipartisan deal between Sens. Chuck GrassleyChuck GrassleyOn The Money: Biden says workers can't turn down job and get benefits | Treasury launches state and local aid | Businesses jump into vax push Grassley criticizes Biden's proposal to provide IRS with B The Hill's Morning Report - Presented by Facebook - Infrastructure, Cheney ouster on deck as Congress returns MORE (R-Iowa) and Ron WydenRonald (Ron) Lee WydenBad jobs report amplifies GOP cries to end 0 benefits boost Putting a price on privacy: Ending police data purchases Overnight Health Care: Biden sets goal of at least one shot to 70 percent of adults by July 4 | White House to shift how it distributes unallocated vaccines to states MORE (D-Ore.), amid blowback from some in the GOP.  

Many GOP senators have concerns with the proposal, worrying that it is too close to price controls on drugs, which Republicans have traditionally opposed. 

ADVERTISEMENT

The support from the administration could help ease concerns, although President TrumpDonald TrumpCaitlyn Jenner says election was not 'stolen,' calls Biden 'our president' Overnight Health Care: FDA authorizes Pfizer vaccine for adolescents | Biden administration reverses limits on LGBTQ health protections Overnight Defense: US fires 30 warning shots at Iranian boats | Kabul attack heightens fears of Afghan women's fates | Democratic Party leaders push Biden on rejoining Iran deal MORE himself has not tweeted or commented publicly on the measure. 

The White House released a supportive statement on Tuesday after the committee unveiled the deal. Trump has made lowering drug prices a priority, though several of his efforts have been withdrawn, increasing pressure on Congress to act. 

Asked about the calls, HHS spokeswoman Caitlin Oakley said: “We are encouraged by the work of the Senate Finance Committee, which reflects many ideas set forth in President Trump’s budget to lower prescription drug costs and reduce out of pocket costs for Americans.”

“Now is the time for seniors to have real protection for their pocketbooks, for drug companies to be held accountable, and for the American patient to finally come first,” she added. 

The most contentious part of the measure for GOP senators is a limit on drug price increases in Medicare’s prescription drug program, called Part D. It would force drug companies to pay money back to Medicare if their prices rose faster than inflation, and is a top priority for Wyden. 

“I haven’t made a final decision,” Sen. Mike CrapoMichael (Mike) Dean CrapoBiden to meet with GOP senators amid infrastructure push Bottom line Senate GOP crafts outlines for infrastructure counter proposal MORE (R-Idaho) said Wednesday. “As you might guess, I’m not happy with the inflation cap.”

Asked if the White House’s support factors into his decision, Crapo said, “It certainly is a factor, but it’s not the entire factor.”

The measure is expected to clear committee with a handful of GOP defections. But its chances of coming to the full Senate for a vote are slimmer, given that Senate Majority Leader Mitch McConnellAddison (Mitch) Mitchell McConnellManchin, Biden huddle amid talk of breaking up T package Romney: Removing Cheney from House leadership will cost GOP election votes The Hill's 12:30 Report - Presented by Facebook - Biden reverses Trump limits on transgender protections MORE (R-Ky.) could be reluctant to vote on a bill that splits Republican senators.